A Guide to an Effective Clinical Trial Protocol in CGMP & CGCP as a Tool for Sustenance of Ethical Principles and Regulatory Requirements in the Pharmaceutical and Research Industry
|Peter Odeh1* and Helen Odeh2|
|1Medical and Technical Service Affairs, ROPAN (NIG) LTD, and Department of Clinical Laboratories, SNBL-CPC, INC, USA|
|2Department of Clinical and Nursing Services, ROPAN (NIG) LTD, USA|
|Corresponding Author :||Peter Odeh
Medical & Technical Service Affairs
ROPAN (NIG) LTD, and Department of Clinical Laboratories
SNBL-CPC, INC, USA
Tel: 443 386 5739
E-mail: [email protected]
|Received January 30, 2014; Accepted February 17, 2014; Published February 19, 2014|
|Citation: Odeh P, Odeh H (2014) A Guide to an Effective Clinical Trial Protocol in CGMP & CGCP as a Tool for Sustenance of Ethical Principles and Regulatory Requirements in the Pharmaceutical and Research Industry. J Clin Trials 4:158. doi:10.4172/2167-0870.1000158|
|Copyright: © 2014 Odeh P, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.|
The Clinical Trial Protoc ol is the foundation upon which the study design is built. According to the Pharmaceutical Research and Manufacturers of America (PhRMA), the primary goal of a trial is to generate new knowledge about a potential medicine so that regulatory authorities can determine whether the medicine is safe and effective and the primary purpose of clinical trial is to advance the knowledge of researchers and regulators so that new treatments and cures can be developed.
A guide to an effective Clinical Trial Protocol in CGMP & CGCP as a tool for sustenance of Ethical Principles and Regulatory requirements in the Pharmaceutical and Research Industry is a contemporary perspective on how professionals in the medical, pharmaceutical and research industries can utilize available resources in developing their clinical trial protocol based on sound scientific and ethical doctrines or principles with the primary intention of protecting research subjects or participants while adding meaning to the necessity for the continuation of research practices in our society.
Additionally, a well-articulated clinical trial protocol and subsequent amendment(s) in practice, as the case may be, will further enhance professionals’ understanding and limitation(s) with greater emphasis on risk management, continuation of the study and importantly when to stop if it is deemed necessary or if the risk/benefit ratio becomes high enough to compromise either the study participants and or compromise ethical principles as enunciated in the Declaration of Helsinki, the Belmont report and the GCP principles contained in the International Conference on Harmonization (ICH).